Literature DB >> 12864798

Detection and localization of chemokine gene expression in autoimmune thyroid disease.

E Helen Kemp1, Russell A Metcalfe, Karen A Smith, M Nicola Woodroofe, Philip F Watson, Anthony P Weetman.   

Abstract

OBJECTIVE: Autoimmune thyroid disease (Hashimoto's thyroiditis and Graves' disease) is characterized by lymphocytic infiltration of the thyroid gland. Chemokines are cytokines with chemoattractant properties for a range of immune effector cells and might therefore play a significant role in the initiation and maintenance of the autoimmune process. The aim of this study was to analyse chemokine gene expression in autoimmune thyroid tissue and in cultured thyroid follicular cells (TFC). DESIGN AND PATIENTS: Immunocytochemistry and reverse-transcriptase polymerase chain reaction (RT-PCR) amplification were used to analyse the expression of monocyte chemoattractant protein (MCP)-1, RANTES (regulated upon activation, normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta, interferon (IFN)-gamma-inducible protein (IP)-10 and monokine induced by IFN-gamma (Mig) in thyroid tissue from patients with Hashimoto's thyroiditis (n = 4), Graves' disease (n = 6) and nonautoimmune multinodular goitre (n = 4). Chemokine gene expression was also examined in cultured TFC by RT-PCR.
RESULTS: Expression of MCP-1, RANTES, MIP-1 alpha, MIP-1 beta, IP-10 and Mig was demonstrated in all Hashimoto's and most Graves' thyroid specimens but very little expression was detected in the nonautoimmune goitre samples. In thyroid tissue from Graves' disease patients, positive staining for chemokines was largely restricted to the lymphocytic cell infiltrate. Within thyroid tissue from Hashimoto's patients, there was evidence for the expression of all chemokines by thyroid follicular cells, suggesting a role for local chemokine synthesis by the glandular epithelial cells in the recruitment of inflammatory cells into the gland in autoimmunity. The present work also showed that expression all the chemokine genes analysed could be induced in cultured thyroid cells by IFN-gamma and interleukin (IL)-1 alpha. Expression of all the chemokines examined was not stimulated by TSH.
CONCLUSION: We postulate that TFC may play a role in the pathogenesis of autoimmune thyroid disease as they are able to express the chemokines MIP-1 alpha, MIP-1 beta, MCP-1, RANTES, IP-10 and Mig that would promote the infiltration of immune cells into the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12864798     DOI: 10.1046/j.1365-2265.2003.01824.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Characterization of Th1- and Th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia.

Authors:  Shu-Fen Zhou; Ji Ma; Hui-Ting Qu; Zong-Tang Liu; Wei-Dong He; Juan-Dong Wang; Ai-Xia Dou; Ni Zhang; Jun-Li Liu; Cheng-Shan Guo; Yan Shi; Ming Hou; Jun Peng
Journal:  J Clin Immunol       Date:  2013-03-14       Impact factor: 8.317

Review 3.  Insights into the role of fibroblasts in human autoimmune diseases.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

4.  Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis.

Authors:  S Görar; E Ademoğlu; A Çarlıoğlu; B Alioğlu; H Bekdemir; B Sağlam; Z Candan; R Üçler; C Culha; Y Aral
Journal:  J Endocrinol Invest       Date:  2015-07-05       Impact factor: 4.256

5.  Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.

Authors:  Tatjana Marinkovic; Alexandre Garin; Yoshifumi Yokota; Yang-Xin Fu; Nancy H Ruddle; Glaucia C Furtado; Sergio A Lira
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

6.  One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders.

Authors:  X Ferrer-Francesch; P Caro; L Alcalde; M P Armengol; Y Ashhab; A Lucas-Martín; E M Martínez-Cáceres; M Juan; R Pujol-Borrell
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

7.  Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.

Authors:  Faina Linkov; Robert L Ferris; Zoya Yurkovetsky; Adele Marrangoni; Lyudmila Velikokhatnaya; William Gooding; Brian Nolan; Matthew Winans; Eric R Siegel; Anna Lokshin; Brendan C Stack
Journal:  Proteomics Clin Appl       Date:  2008-10-10       Impact factor: 3.494

8.  Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

Authors:  Erin F Gillespie; Nupur Raychaudhuri; Konstantinos I Papageorgiou; Stephen J Atkins; Ying Lu; Laya K Charara; Tünde Mester; Terry J Smith; Raymond S Douglas
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-21       Impact factor: 4.799

9.  High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Emiliano Ghiri; Santino Marchi; Michele Colaci; Fabrizio Bruschi; Poupak Fallahi
Journal:  Clin Rheumatol       Date:  2009-06-20       Impact factor: 2.980

10.  Aberrant MRP14 expression in thyroid follicular cells mediates chemokine secretion through the IL-1β/MAPK pathway in Hashimoto's thyroiditis.

Authors:  Xuan Luo; Tingting Zheng; Chaoming Mao; Xin Dong; Xiao Mou; Chengcheng Xu; Qingyan Lu; Baocui Liu; Shengjun Wang; Yichuan Xiao
Journal:  Endocr Connect       Date:  2018-05-15       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.